🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06743321
Starting soon Not applicable

Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients

NCT06743321 · tracked via the Priya Life Science China tracker
Sponsor
Peking Union Medical College Hospital
Phase
Not applicable
Started
2026-08-01
Last updated
2026-03-25

Condition(s) studied

Critical Care Nursing

Investigational drug(s) / intervention(s)

Speech-to-speech Voice-Cloning Care (SVCC)

Speech-to-speech Voice-Cloning Care (SVCC): After patients in the intervention group were transferred to the ICU, the SVCC intervention was initiated. It is administered three times daily: in the morning, at noon, and in the evening. The SVCC intervention includes three types of activities: awakening, reassurance, and preparatory exercises for the removal of the endotracheal tube (ETT). Before each intervention is carried out, the clinical status of the participants must be assessed to determine whether they are suitable for SVCC and to decide on the specific content of the intervention. Once the removal of the ETT is implemented, the SVCC intervention will no longer be carried out.

Study summary

The goal of this clinical trial is to learn the effect of Speech-to-speech Voice-Cloning Care (SVCC) on improving ICU-acquired anxiety for critically ill patients. The main question it aims to answer is:

* Can the use of participants' loved ones' voices by nurses in communication while providing care lead to better mental health and clinical outcomes?

Researchers will see if the implementation of SVCC can reduce anxiety and depression and improve clinical outcomes.

Participants will:

* Receive the SVCC intervention until the endotracheal tube (ETT) is removed.
* Keep a diary of delirium, the duration of mechanical ventilation, and ICU stays.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Expected mechanical ventilation time \> 24 hours; * Expected ICU stay \> 72 hours; * Language: Chinese; * Richmond Agitation-Sedation Scale (RAAS) score ≥ -2 points; * Hemodynamic stability. Exclusion Criteria: * Severe hearing impairment or worse (Grade 3 or higher according to WHO's Grades of hearing impairment); * Disorders of consciousness or comprehension; * Mental or psychological disorders that are being treated with medication; * Head trauma or surgery resulting in an inability to wear earphones.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Peking Union Medical College Hospital Beijing Beijing Municipality

More Peking Union Medical College Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06743321 on ClinicalTrials.gov ↗ ← All trials in China